...
search icon
cntb-img

Connect Biopharma Holdings Ltd Share Price

CNTB
NMQ
$2.93
+$0.09
(3.17%)
1D
Industry: Biotechnology Sector: Health Care

Connect Biopharma Holdings Ltd Analyst Forecast

Connect Biopharma Holdings Ltd Share Price Chart

Connect Biopharma Holdings Ltd Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$158.77M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
118.76K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.18
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.51 L
$3.28 H
$2.93

About Connect Biopharma Holdings Ltd, Common Stock

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States. The company's lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is in Phase 3 studies for the treatment of inflammatory diseases such as atopic dermatitis and asthma. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California. more

Industry: BiotechnologySector: Health Care

Connect Biopharma Holdings Ltd Stock Returns

Time FrameCNTBSectorS&P500
1-Week Return9.33%0.72%-1.31%
1-Month Return27.39%1.27%0.78%
3-Month Return14.01%3.13%3.46%
6-Month Return52.6%15.81%6.19%
1-Year Return221.8%8.89%11.68%
3-Year Return171.3%20.79%71.21%
5-Year Return-84.15%35.89%74.81%

Connect Biopharma Holdings Ltd Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue----26.03M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue--1.03M988.00K660.00K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":95.86,"profit":true},{"date":"2024-12-31","value":64.04,"profit":true}]
Gross Profit--(1.03M)(988.00K)26.03M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-3.96,"profit":false},{"date":"2023-12-31","value":-3.8,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin----100.00%[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses29.36M97.59M114.69M62.07M48.48M[{"date":"2020-12-31","value":25.6,"profit":true},{"date":"2021-12-31","value":85.09,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":54.13,"profit":true},{"date":"2024-12-31","value":42.28,"profit":true}]
Operating Income(30.30M)(99.15M)(117.66M)(62.07M)(22.45M)[{"date":"2020-12-31","value":-3029531300,"profit":false},{"date":"2021-12-31","value":-9915186900,"profit":false},{"date":"2022-12-31","value":-11766164400,"profit":false},{"date":"2023-12-31","value":-6207400000,"profit":false},{"date":"2024-12-31","value":-2245200000,"profit":false}]
Total Non-Operating Income/Expense(91.25M)(102.64M)10.17M5.38M11.50M[{"date":"2020-12-31","value":-793.48,"profit":false},{"date":"2021-12-31","value":-892.48,"profit":false},{"date":"2022-12-31","value":88.41,"profit":true},{"date":"2023-12-31","value":46.8,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(119.37M)(204.94M)(116.12M)(59.38M)(15.40M)[{"date":"2020-12-31","value":-11936947700,"profit":false},{"date":"2021-12-31","value":-20493887200,"profit":false},{"date":"2022-12-31","value":-11611767900,"profit":false},{"date":"2023-12-31","value":-5938300000,"profit":false},{"date":"2024-12-31","value":-1540500000,"profit":false}]
Income Taxes934.46K266.47K297.52K120.00K223.00K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":28.52,"profit":true},{"date":"2022-12-31","value":31.84,"profit":true},{"date":"2023-12-31","value":12.84,"profit":true},{"date":"2024-12-31","value":23.86,"profit":true}]
Income After Taxes(120.30M)(205.21M)(116.42M)(59.50M)(15.63M)[{"date":"2020-12-31","value":-12030393600,"profit":false},{"date":"2021-12-31","value":-20520534500,"profit":false},{"date":"2022-12-31","value":-11641519600,"profit":false},{"date":"2023-12-31","value":-5950300000,"profit":false},{"date":"2024-12-31","value":-1562800000,"profit":false}]
Income From Continuous Operations(779.23M)(1.31B)(797.05M)(59.50M)(15.63M)[{"date":"2020-12-31","value":-77922500000,"profit":false},{"date":"2021-12-31","value":-130682400000,"profit":false},{"date":"2022-12-31","value":-79705500000,"profit":false},{"date":"2023-12-31","value":-5950300000,"profit":false},{"date":"2024-12-31","value":-1562800000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(120.30M)(205.21M)(116.42M)(59.50M)(15.63M)[{"date":"2020-12-31","value":-12030393600,"profit":false},{"date":"2021-12-31","value":-20520534500,"profit":false},{"date":"2022-12-31","value":-11641519600,"profit":false},{"date":"2023-12-31","value":-5950300000,"profit":false},{"date":"2024-12-31","value":-1562800000,"profit":false}]
EPS (Diluted)----(0.96)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-96,"profit":false}]

Connect Biopharma Holdings Ltd Ratios

Connect Biopharma Holdings Ltd Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

CNTB
Current Ratio 5.48

Connect Biopharma Holdings Ltd Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CNTB
ROA (LTM) -38.67%
ROE (LTM) -66.80%

Connect Biopharma Holdings Ltd Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CNTB
Debt Ratio Lower is generally better. Negative is bad. 0.18
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.82

Connect Biopharma Holdings Ltd Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CNTB
Trailing PE NM
Forward PE 0.77
P/S (TTM) 208.35
P/B 2.64
Price/FCF NM
EV/R 120.81
EV/Ebitda 0.19

FAQs

What is Connect Biopharma Holdings Ltd share price today?

Connect Biopharma Holdings Ltd (CNTB) share price today is $2.93

Can Indians buy Connect Biopharma Holdings Ltd shares?

Yes, Indians can buy shares of Connect Biopharma Holdings Ltd (CNTB) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CNTB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Connect Biopharma Holdings Ltd be purchased?

Yes, you can purchase fractional shares of Connect Biopharma Holdings Ltd (CNTB) via the Vested app. You can start investing in Connect Biopharma Holdings Ltd (CNTB) with a minimum investment of $1.

How to invest in Connect Biopharma Holdings Ltd shares from India?

You can invest in shares of Connect Biopharma Holdings Ltd (CNTB) via Vested in three simple steps:

  • Click on Sign Up or Invest in CNTB stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Connect Biopharma Holdings Ltd shares
What is Connect Biopharma Holdings Ltd 52-week high and low stock price?

The 52-week high price of Connect Biopharma Holdings Ltd (CNTB) is $3.28. The 52-week low price of Connect Biopharma Holdings Ltd (CNTB) is $0.51.

What is Connect Biopharma Holdings Ltd price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Connect Biopharma Holdings Ltd (CNTB) is

What is Connect Biopharma Holdings Ltd price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Connect Biopharma Holdings Ltd (CNTB) is 2.64

What is Connect Biopharma Holdings Ltd dividend yield?

The dividend yield of Connect Biopharma Holdings Ltd (CNTB) is 0.00%

What is the Market Cap of Connect Biopharma Holdings Ltd?

The market capitalization of Connect Biopharma Holdings Ltd (CNTB) is $158.77M

What is Connect Biopharma Holdings Ltd's stock symbol?

The stock symbol (or ticker) of Connect Biopharma Holdings Ltd is CNTB

How Can Investors Use Connect Biopharma Holdings Ltd Share Price Data for Long-Term Investment Decisions?

Consider the share price of Connect Biopharma Holdings Ltd as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Connect Biopharma Holdings Ltd has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Connect Biopharma Holdings Ltd shares for Indian investors?

When investing in Connect Biopharma Holdings Ltd shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Connect Biopharma Holdings Ltd stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Connect Biopharma Holdings Ltd share price with other stocks in the same sector?

Rather than merely checking the share price of Connect Biopharma Holdings Ltd and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Connect Biopharma Holdings Ltd stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top